Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.18B | 1.89B | 1.74B | 1.58B |
| Total Other Revenue | 28.96M | 31.35M | 31.78M | 36.22M | 27.91M |
| Total Revenue | 2.48B | 2.21B | 1.92B | 1.77B | 1.61B |
| Cost of Revenue | 2.02B | 1.80B | 1.57B | 1.40B | 1.22B |
| Gross Profit | 459.13M | 405.75M | 355.10M | 374.81M | 383.65M |
| SG&A Expenses | 476.38M | 461.74M | 439.75M | 431.66M | 424.71M |
| Depreciation & Amortization | 1.91M | 1.74M | 1.69M | 1.61M | 1.54M |
| Other Operating Expenses | -800.00K | -800.00K | -800.00K | -800.00K | -- |
| Total Operating Expenses | 2.49B | 2.27B | 2.01B | 1.83B | 1.65B |
| Operating Income | -18.36M | -56.92M | -85.53M | -57.66M | -42.60M |
| Income Before Tax | -18.36M | -56.94M | -85.55M | -57.71M | -42.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.36 | -56.94 | -85.55 | -57.71 | -42.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -611.00K | -981.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.36M | -56.94M | -85.55M | -58.32M | -43.10M |
| EBIT | -18.36M | -56.92M | -85.53M | -57.66M | -42.60M |
| EBITDA | -16.46M | -55.19M | -83.84M | -56.05M | -41.06M |
| EPS Basic | -0.04 | -0.11 | -0.17 | -0.12 | -0.09 |
| Normalized Basic EPS | -0.02 | -0.07 | -0.10 | -0.07 | -0.05 |
| EPS Diluted | -0.04 | -0.11 | -0.17 | -0.12 | -0.09 |
| Normalized Diluted EPS | -0.02 | -0.07 | -0.10 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 2.08B | 2.06B | 2.04B | 2.01B | 1.99B |
| Average Diluted Shares Outstanding | 2.10B | 2.06B | 2.04B | 2.01B | 1.99B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |